Mangrove Capital Partners

Mangrove operates as a contrarian, early-stage venture capital firm that concentrates on Europe and Israel. Deployment is split evenly between the two regions, and the firm regularly partners with founders prior to product launch. The portfolio spans enterprise software, digital health, AI and data infrastructure. Mangrove emphasizes a high-conviction, anchor-partner approach, often taking significant early stakes rather than indexing across a large volume of deals.

Yannick Oswald is the firm's most prominent public-facing partner and author of its market commentaries. The broader partnership operates from Luxembourg and Tel Aviv, with deal professionals based in Berlin, Paris, Barcelona and London. No formal investment committee structure is publicly detailed by the firm.

Mangrove lists eight unicorns among its early-stage investments: Skype, Wix, Flo Health, WalkMe, K Health, Project B, and TBOL. Two additional unicorns beyond these seven are not individually named on the current firm website. Dealroom has ranked Mangrove eighth among seed investors in the EMEA region.

Mangrove maintains a dedicated office on Yigal Alon Street in Tel Aviv, staffed with a local investment team. The firm distributes its capital allocation evenly between European and Israeli opportunities, treating the Israeli market as one of its two core geographies rather than a satellite region. The Tel Aviv office covers what Mangrove describes as one of the most promising tech hotspots globally.

The Mangrove Foundation is a philanthropic vehicle initiated by Mangrove Capital Partners to support environmental and humanitarian causes the partnership collectively selects. It operates as the firm's primary charitable structure. No separate management or asset pool is detailed, and the foundation appears closely tied to the principal investment entity.

No. Mangrove has not publicly disclosed its assets under management, individual fund sizes, or net returns. The firm references six funds and cites an average return metric but does not publish the underlying figures. Its public narrative focuses instead on unicorn count, portfolio-company milestones, and founder endorsements.

Mangrove presents itself as an anchor investor that leads early-stage rounds, often serving as the first institutional check. While co-investment alongside other venture firms occurs regularly in syndicated rounds, the firm does not publicly formalize a co-investment program for external limited partners. Its emphasis is on direct relationships with founding teams rather than operating a fund-of-funds or club-deal structure.